Etanercept in psoriasis treatment
- PMID: 15314989
Etanercept in psoriasis treatment
Abstract
More recently, lots of new drugs regulating the several steps of immune reaction have been introduced for psoriasis treatment. These include TNF-alpha inhibitors. One of such inhibitors is Etanercept--a monoclonal antibody connected with human IgG1 binding the soluble form of TNF-alpha receptor. We present the literature data concerning the attempts of Etanercept treatment and local and general complications of its use.
Similar articles
-
Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience.J Eur Acad Dermatol Venereol. 2009 Aug;23(8):979-82. doi: 10.1111/j.1468-3083.2009.03093.x. J Eur Acad Dermatol Venereol. 2009. PMID: 19470056 No abstract available.
-
Etanercept for psoriasis: two case reports.Int J Clin Pharmacol Res. 2005;25(4):159-63. Int J Clin Pharmacol Res. 2005. PMID: 16402631
-
Efficacy of etanercept for the treatment of psoriasis: an overview of the Italian clinical experience from the real-life setting and independent studies.Immunopharmacol Immunotoxicol. 2012 Dec;34(6):901-6. doi: 10.3109/08923973.2012.692381. Epub 2012 Jun 11. Immunopharmacol Immunotoxicol. 2012. PMID: 22686544 Review.
-
Adolescent plaque psoriasis: our experience using etanercept.J Eur Acad Dermatol Venereol. 2009 Aug;23(8):976-7. doi: 10.1111/j.1468-3083.2008.03081.x. Epub 2009 Jan 13. J Eur Acad Dermatol Venereol. 2009. PMID: 19207668 No abstract available.
-
Etanercept for the treatment of psoriasis.Skin Therapy Lett. 2006 Feb;11(1):1-4. Skin Therapy Lett. 2006. PMID: 16485060 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical